The Application Value of Spectral CT in the Accurate Staging of Liver Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: To explore the value of spectral CT in the diagnosis and treatment of liver cancer.
- Who it may be relevant to
- Registry conditions: Liver Cancer. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Spectral CT was used to prospectively collect medical images and clinical data related to liver cancer, evaluate the effect of image quality in the diagnosis of liver cancer, and evaluate the application value in the accurate staging of liver cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
Interventions
- Diagnostic test To explore the value of spectral CT in the diagnosis and treatment of liver cancer
The CT scan is part of the standard treatment protocol.
Primary outcome measures
- Pathological TNM staging [Time frame: 1 day]
Eligibility criteria
Inclusion criteria
- Undergo a contrast-enhanced Quark Spectral CT scan of the lower abdomen/pelvis within 1 week before treatment.
- Age > 18 years.
- Patients suspected of having liver cancer.
- Patients who have signed the informed consent form.
Exclusion criteria
- Severe cardiac, pulmonary, or renal insufficiency.
- Allergy to iodine-based contrast agents.
- Inability to cooperate with the CT examination.
- Poor image quality of the Quark Spectral CT scan.
- Women who are pregnant or breastfeeding.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Diagnostic
Study locations
China · 1 center
- Yunnan Cancer Hospital — Kunming
Identifiers
NCT: NCT06977399 · KYLX2025-108